BioGeneriX to Develop Second Protein Using Neose’s GlycoPEGylation(TM) Technology
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 60 (Table of Contents)
Published: 5 Jun-2005
DOI: 10.3833/pdr.v2005.i60.664 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
BioGeneriX exercised its option for the development of a long-acting, next generation version of a therapeutic protein using Neose’s enzymatic GlycoPEGylation(TM) technology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS